Pharma Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allerca
Allerca unveils hypoallergenic cats bred for allergic consumers
July 4th, 2006
Allerca unveiled the world's first scientifically proven hypoallergenic cats that allow allergic consumers to enjoy the love and companionship of a pet without the cost, inconvenience, risk and limited effectiveness of current feline allergy treatments. Allerca's first customers are expected to take delivery of their hypoallergenic kittens in early 2007. The Allerca hypoallergenic cat is the first of a planned series of lifestyle pets that Allerca will develop over the next few years. By using proprietary genetic technology, Allerca manipulated naturally occurring genetic variations in cats, specifically targeting the gene Fel D1 that is responsible...
Source: Pharma Law Weekly (2006-07-04)
|
